找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cerebral Ischemic Reperfusion Injuries (CIRI); Bench Research and C Weijian Jiang,Wengui Yu,John H. Zhang Book 2018 Springer International

[复制链接]
楼主: indulge
发表于 2025-3-26 21:46:43 | 显示全部楼层
Therapeutic Window Beyond Cerebral Ischemic Reperfusion Injury,ion. In patients with acute stroke from LVO in the posterior circulation, EVT up to 48 h after symptom onset was seldom futile in the absence of extensive baseline ischemia and longer treatment delay does not increase the risk of sICH. Such clinical studies have clearly pushed the boundary of our un
发表于 2025-3-27 05:04:26 | 显示全部楼层
Book 2018hensive Stroke & Cerebrovascular Center, University of California, Irvine. . YanQu, Professor and Director of Neurosurgery at the Second Affiliated Hospital of Air Force Medical University, Xi’an, China.. . Zhongsong Shi, Professor of Neurosurgery at Sun Yat-sen Memorial Hospital, Sun Yat-sen Univer
发表于 2025-3-27 09:09:19 | 显示全部楼层
发表于 2025-3-27 12:54:08 | 显示全部楼层
发表于 2025-3-27 14:10:12 | 显示全部楼层
发表于 2025-3-27 21:12:54 | 显示全部楼层
Null-Indication in AC Bridge Circuitsosis, autophagy and programmed necrosis (also known as necroptosis). In this review we will discuss the characteristics, molecular mechanism of each PCD mode and their role in cerebral ischemia and reperfusion injury (CIRI), furthermore crosstalk between various modes of PCD is also dicussed.
发表于 2025-3-27 23:57:32 | 显示全部楼层
Oscilloscope Measuring Techniquetriggers a detrimental pathophysiological cascade resulting in severe vascular dysfunction and I/R injury which result in poor outcome after stroke in this population. The various aspects of diabetic stroke induced vascular and reperfusion damage and the underlying mechanisms are discussed in this chapter.
发表于 2025-3-28 04:40:59 | 显示全部楼层
发表于 2025-3-28 08:43:47 | 显示全部楼层
Characters of Ischemic Stroke and Recanalization Arteries,hapter, the issues were reviewed as follows: the epidemiology, risk factors, imaging, diagnosis and pathophysiology of ischemic stroke, as well as intravenous thrombolytic and antiplatelet therapy, endovascular treatment, antioxidant and reperfusion injury after artery recanalization.
发表于 2025-3-28 10:54:01 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-23 15:24
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表